List view / Grid view

Abeona Therapeutics



Abeona Therapeutics completes cohort in Sanfilippo syndrome trial

30 August 2016 | By Niamh Louise Marriott, Digital Content Producer

The first-in-man clinical trial utilises a single injection of AAV gene therapy for patients with MPS IIIA (Sanfilippo syndrome type A), a rare autosomal recessive disease that causes neurocognitive decline, speech loss, loss of mobility, and premature death...